Last edited by Akikora
Tuesday, April 21, 2020 | History

2 edition of role of von Willebrand factor in uremic bleeding found in the catalog.

role of von Willebrand factor in uremic bleeding

Jacqueline Ann Brassard

role of von Willebrand factor in uremic bleeding

  • 221 Want to read
  • 27 Currently reading

Published .
Written in English

    Subjects:
  • Von Willebrand factor.,
  • Uremia.

  • Edition Notes

    Statementby Jacqueline Ann Brassard.
    The Physical Object
    Paginationxii, 126 leaves, bound :
    Number of Pages126
    ID Numbers
    Open LibraryOL16879728M

      M Furlan: Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome Adv Nephrol Necker Hosp 71 – 81, Medline, Google Scholar D Caramazza, G Quintini, I Abbene, etal: Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The role of Cited by: Chapter 3 Factor VIII concentrate infusion in patients with hemophilia results in decreased von Willebrand Factor and ADAMTS activity 35 Chapter 4 Platelet behaviour is not related to bleeding phenotype in severe hemophilia A patients 51 Chapter 5 FVIII uptake by platelets and megakaryocytes desmopressin adiuretin minirin desmopressin acetate DDAVP A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Molecular weight.


Share this book
You might also like
Attrition

Attrition

English linguistics 1500-1800.

English linguistics 1500-1800.

ARF comparability study

ARF comparability study

The people of the sierra

The people of the sierra

Computational analysis of high resolution unsteady airloads for rotor aeroacoustics

Computational analysis of high resolution unsteady airloads for rotor aeroacoustics

Early childhood project

Early childhood project

Applied multivariate statistical analysis

Applied multivariate statistical analysis

Play in the infants school

Play in the infants school

ORACLE CORP.

ORACLE CORP.

Grids of change

Grids of change

Achievement; Country, Liberal.

Achievement; Country, Liberal.

Notes on forestry in Burma.

Notes on forestry in Burma.

Salesmanship

Salesmanship

Similarities and universality in relativistic flows

Similarities and universality in relativistic flows

Parsons Diseases of the Eye

Parsons Diseases of the Eye

Betty MacDonalds Onions in the stew

Betty MacDonalds Onions in the stew

role of von Willebrand factor in uremic bleeding by Jacqueline Ann Brassard Download PDF EPUB FB2

Von Willebrand factor (VWF) (/ ˌ f ʌ n ˈ v ɪ l ɪ b r ɑː n t /) is a blood glycoprotein involved in is deficient and/or defective in von Willebrand disease and is involved in many other diseases, including thrombotic thrombocytopenic purpura, Heyde's syndrome, and possibly hemolytic–uremic syndrome.

Increased plasma levels in many cardiovascular, neoplastic, and. von Willebrand factor (VWF) (/ ˌ f ʌ n ˈ v ɪ l ɪ b r ɑː n t /) is a blood glycoprotein involved in is deficient and/or defective in von Willebrand disease and is involved in many other diseases, including thrombotic thrombocytopenic purpura, Heyde's syndrome, and possibly hemolytic–uremic syndrome.

Increased plasma levels in many cardiovascular, neoplastic, and Aliases: VWF, F8VWD, von Willebrand factor. Along with haemophilia A and B, von Willebrand disease (VWD) and rare bleeding disorders (RBDs) cover all inherited bleeding disorders of coagulation. Bleeding tendency, which can range from extremely severe to mild, is the common symptom.

VWD, due to a deficiency and/or abnormality of von Willebrand factor (VWF), represents the most frequent bleeding disorder, Cited by: ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13)—also role of von Willebrand factor in uremic bleeding book as role of von Willebrand factor in uremic bleeding book Willebrand factor-cleaving protease (VWFCP)—is a zinc-containing metalloprotease enzyme that cleaves von Role of von Willebrand factor in uremic bleeding book factor (vWf), a large protein involved in blood is secreted into the blood and degrades large vWf multimers, decreasing their Aliases: ADAMTS13, ADAM-TS13, ADAMTS.

Introduction. Von Willebrand disease (VWD) is the most common inherited bleeding disorder, with a prevalence of approximately 1–2% according to population studies, 1 but clinically relevant cases have a fold lower prevalence.

2 The disorder is mainly transmitted in an autosomal dominant manner and is caused by the deficiency or abnormality of VWF, which Cited by: The pathogenesis of acute renal failure–related bleeding is considered multifactorial and includes elements that can be divided roughly into three categories: uremia-related factors, dialysis-related factors, and critical care-related factors.

14 Bleeding tendency in uremic patients has been evaluated extensively, with abnormalities in. Von Willebrand disease (VWD) is a common bleeding disorder caused by reduced von Willebrand factor (VWF) synthesis or synthesis of a functionally defective VWF protein.

Studies of VWD vary widely in terms of the minimal laboratory or clinical attributes required for the appropriate by: 2. Von Willebrand factor (vWF) is a blood glycoprotein of the coagulation system.

It is deficient or defective in von Willebrand disease and is involved in a large number of other diseases, including thrombotic thrombocytopenic purpura, Heyde's syndrome. A client diagnosed with autosomal dominant von Willebrand factor disease (vWF) is experiencing mild to moderate bleeding.

The health care provider would classify the diagnosis as: Type 2 -Type 1 -Type 3 - Type 4. Von Willebrand factor (vWF) is a blood glycoprotein involved in hemostasis.

It is deficient or defective in role of von Willebrand factor in uremic bleeding book Willebrand disease and is involved in a large number of other diseases, including thrombotic thrombocytopenic purpura, Heyde’s syndrome.

Classically, bleeding time was used to evaluate the bleeding risk in uremic patients; however, it is a cumbersome test that cannot predict true bleeding risk. The PFA can be used to detect disturbances in VWF and platelet adhesion but is less role of von Willebrand factor in uremic bleeding book to pick up some platelet secretion or activation : Susmita N.

Sarangi, Suchitra S. Acharya. Desmopressin (1-deaminoD-arginine vasopressin) is a synthetic analog of vasopressin aka antidiuretic hormone created in used in the treatment in a wide variety of medical conditions to include nocturnal polyuria, hemophilia A, diabetes insipidus, on Willebrand disease, uremic bleeding, as well as many off label uses such as an adjunct with hypertonic saline to prevent.

Von Willebrand factor (VWF) is a blood glycoprotein that is required for normal hemostasis, and deficiency of VWF, or von Willebrand disease (VWD), is Author: Pier Mannuccio Mannucci. The formation of platelet-rich thrombi, a critical step in the pathogenesis of atherothrombotic events, is a multistep process involving several components, among which von Willebrand Factor.

Uremic patients develop an acquired platelet dysfunction that results in bleeding complications. The pathogenesis of this hemostatic dysfunction is multifactorial and includes effects of. A hereditary cause is suspected if there is a lifelong history of easy bruising; bleeding after tooth extractions, surgery, childbirth, or circumcision; or heavy menstruation.

In the case of a suspected hereditary cause, von Willebrand factor (VWF) antigen and VWF activity studies are. VWD is not primarily a disorder of platelet function, but a disorder of von Willebrand factor (VWF).2 Because of the key role of VWF in platelet adhesion via its binding to the GPIb-IX-V complex (Chapters 10 and 20), VWD results, however, in a platelet adhesion defect.

The bleeding diathesis-reducing effect of conjugated estrogen emerged on the basis of observational data (Liu et al., ). Following these observational data, the effect on uremic bleeding diathesis began being investigated.

It has been shown that use of mg/kg ıv ( days) in uremic patients lowers bleeding time (Viganò et al., ).Cited by: 1.

Von Willebrand disease (VWD) is the most common bleeding disorder among women with menorrhagia, affecting up to 20% of such patients. Besides menorrhagia, important consequences of bleeding disorders in premenopausal women include iron deficiency anemia, miscarriage, postpartum bleeding, uterine bleeding and by: Tsai HM, Chandler WL, Sarode R, et al.

von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli OH7-associated hemolytic uremic syndrome.

Pediatr Res. ; 49 (5)– [Google Scholar]. As its function is dependent on requirements such as a resting level of F VIII and a von Willebrand factor of at least 10% and, in addition, on a platelet number of at least 50 × 10 9 /l and on certain platelet membrane receptors and contents, a precise diagnosis of the bleeding disorder is necessary before the application of DDAVP can be Cited by:   Albánez S, Michels A, Sponagle K, Lillicrap D () Age-related increases in plasma factor VIII and Von Willebrand factor in a C57BL/6 mouse model are associated with increased factor VIII and Von Willebrand factor gene expression and reduced expression of the clearance receptor, StabilinCited by:   Wagner DD () Storage and secretion of von Willebrand factor.

In: Zimmerman TS, Ruggeri ZM (eds) Coagulation and bleeding disorders. The role of factor VIII and von Willebrand factor. Dekker, New York, pp – Google ScholarCited by: Publications of J. Evan Sadler, MD, PhD, Professor in the Hematology Division, Washington University in St.

Louis. The process by which the body controls bleeding and maintains blood in fluid form is _____. Its components are vascular (vasoconstriction), platelets. Easy bruisability, nosebleeds, heavy menses, excessive bleeding after tooth extraction or dental procedures Relating to Von Willebrand's Factor, _____ is a necessary portein for platelet adhession and is a receptor for glycoprotein _____ and _____ and ____.

William L. Nichols is a Hematologist in Rochester, MN. Find Dr. Nichols's phone number, address, insurance information, hospital affiliations and more. Potential etiologies include the accumulation of uremic toxins (e.g., guanidinosuccinic acid), overproduction of nitric oxide due to induction of constitutive endothelial nitric oxide synthase, dysfunctional von Willebrand factor (vWF), and anemia.

4,5 A report from the European Uremic Toxin Work Group described over 80 retained solutes that Author: Jimmy Gonzalez, Samantha Bryant, Evelyn R. Hermes-DeSantis, Evelyn R. Hermes-DeSantis. Von Willebrand factor (vWF) is a blood glycoprotein involved in hemostasis.

It is deficient or defective in von Willebrand disease and is involved in a large number of other diseases, including thrombotic thrombocytopenic purpura, Heyde’s syndrome, and possibly hemolytic-uremic syndrome. Coagulation and Bleeding Disorders: The Role of Factor VIII and von Willebrand Factor Chapter: Molecular biology of von Willebrand factor.

Page - Sadler JE Editors: TS Zimmerman and Z Dekker, Inc., New York, NY ; Thrombosis and Haemostasis Chapter: The molecular biology of von Willebrand factor. Page 61 - 79 Sadler JEOccupation: Physician.

von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J.

; 23 44 Catto A J, Carter A M, Barrett J H. et al. von Willebrand factor and factor VIII: C in acute cerebrovascular by: Management of Spontaneous Bleeding and Prevention of Bleeding After Dental Extractions and Other Surgical Procedures in Mild Hemophilia a and Von Willebrand’s Disease: Ten Years of Experience at the Vicenza Hemophilia and Thrombosis Center.

Pages Castaman, Giancarlo (et al.). Clotting Factor Release in vivo p. Non-Responsiveness of t-PA, u-PA, and vWF to DDAVP p. Control of Bleeding in Uremic Patients p.

Hemostatic Effectiveness of Desmopressin in the Bleeding Disorders of Uremia p. Renal Function and Thromboembolism in High Dose Desmopressin Treatment p.

Inherited deficiencies have been identified in von Willebrand factor cleaving protease (ADAMTS13 - ADAM metallopeptidase with thrombospondin type 1 motif 13), complement factor H, 1, and B, and defects in vitamin B12 metabolism (2).

Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

J Clin Invest ; Thrombotic thrombocytopenic purpura (TTP) is a blood disorder that results in blood clots forming in small blood vessels throughout the body.

This results in a low platelet count, low red blood cells due to their breakdown, and often kidneys, heart, and brain ms may include large bruises, fever, weakness, shortness of breath, confusion, and headache.

VON WILLEBRAND FACTOR Glycoprotein and the larger of the two components of the factor VIII/von Willebrand complex. Gene controlling the production of vWf is located on chromosome Synthesized in endoplasmic reticulum and golgi region of megakaryocytes and endothelial cells.

Stored in Weibel-Palade bodies of the endothelial cells and α. Furlan M, Robles R, Galbusera M, et al: Von Willebrand factor–cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

N Engl J Med –, Tsai HM, Lian EC: Antibodies to von Willebrand factor–cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J MedGet this from a library. Transfusion medicine and hemostasis: clinical and laboratory aspects.

[Christopher D Hillyer;] -- This new handbook in transfusion medicine and hemostasis aims to combine clinical and laboratory information from two fields which have high degrees of overlap into one concise, easy-to-use pocket. Abstract. von Willebrand factor (VWF) is an adhesive plasma protein that primarily acts to bridge platelets to sites of vascular injury and thus prevent bleeding.

von Willebrand disease (VWD) is the most common inherited bleeding disorder and is caused by deficiency and/or defects of VWF, leading to low levels of plasma VWF or dysfunctional by:. Since von Willebrand factor helps platelets clot together and stick to pdf vessel walls, having adequate pdf of ADAMTS13 prevents those big proteins from forming unnecessary blood clots.

Diagnosis of TTP involves an ADAMTS13 test (assay) to determine its activity percent, with low results noted in about 80% of patients with thrombotic.Cryoprecipitate should not be used to treat von Willebrand’s disease except in life and limb-threatening emergencies when multimeric vWF-containing Factor VIII concentrate (Humate P, Alphanate, or Koate DVI) is not immediately available.

A reasonable dose of cryoprecipitate is 1 bag for every 10 Kg of body weight.You can write a book review ebook share your experiences. Other readers will always be interested in your opinion of the books you've read.

Whether you've loved the book or not, if you give your honest and detailed thoughts then people will find new books that are right for them.